Pionner in plant biotechnology, GREENTECH develops and produces for cosmetic, pharmaceutical and nutraceutical fields high tech active ingredients from plants, marine and microbial worlds.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHYLAGEN, A BIOTECH COMPANY LAUNCHES PHYLAGEN SURFACE™ SARS-COV-2 TEST KIT TO DETECT THE VIRUS

Phylagen | July 31, 2020

news image

Phylagen, an award-winning biotech company specializing in decoding the environmental microbiome for indoor safety, today announced the national availability of its Phylagen Surface™ SARS-CoV-2 (COVID-19) test kit. Designed to be used by anyone on any surface, Phylagen Surface™ provides an early indication of outbreaks in shared spaces including nursing homes, schools, hospitals, restaurants, offices and retail shops."Surface testing can help curb the spread of COVID-19 bu...

Read More

Industry Outlook

ENVEDA BIOSCIENCES UNVEILS NEW AI ALGORITHM TO UNLOCK NATURE’S CHEMICAL CODE

Businesswire | June 26, 2023

news image

Enveda Biosciences, a biotechnology company discovering new medicines from natural sources, released the details of one of its foundational AI models, MS2Mol, in a pre-print posted on ChemRxiv. MS2Mol is designed to predict the structure of metabolites, which are the building blocks and breakdown products of the cell. Despite their essential role in all cell processes, it is estimated that less than 1% of all naturally-occurring metabolites are known to science. The ability of MS2Mol to ra...

Read More

MedTech, Industrial Impact

TWIST BIOSCIENCE ENTERS INTO THIRD COLLABORATION WITH ASTELLAS TO SUPPORT ANTIBODY DISCOVERY FOR IMMUNOTHERAPIES

Businesswire | April 21, 2023

news image

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. by which Astellas will license a suite of Twist’s VHH antibody libraries to be used by Astellas for drug discovery and development. “We are pleased to extend our collaboration with Astellas to three agreements across two groups within the company, showcasing our ab...

Read More

Medical

BE BIO AND RESILIENCE ANNOUNCE STRATEGIC COLLABORATION TO MANUFACTURE ENGINEERED B CELLS, A NEW CLASS OF CELLULAR MEDICINES

Be Bio | May 20, 2022

news image

Be Biopharma, Inc. (“Be Bio”) and National Resilience, Inc. (Resilience) today announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline. Be Bio’s proprietary engineered B Cell Medicines (BeCM) platform is harnessing the power of the human B cell to create a new class of autologous and allogeneic cellular medicines that durably and redosably produce therapeutic proteins in vivo without toxic pre-conditioning. The two ...

Read More
news image

PHYLAGEN, A BIOTECH COMPANY LAUNCHES PHYLAGEN SURFACE™ SARS-COV-2 TEST KIT TO DETECT THE VIRUS

Phylagen | July 31, 2020

Phylagen, an award-winning biotech company specializing in decoding the environmental microbiome for indoor safety, today announced the national availability of its Phylagen Surface™ SARS-CoV-2 (COVID-19) test kit. Designed to be used by anyone on any surface, Phylagen Surface™ provides an early indication of outbreaks in shared spaces including nursing homes, schools, hospitals, restaurants, offices and retail shops."Surface testing can help curb the spread of COVID-19 bu...

Read More
news image

Industry Outlook

ENVEDA BIOSCIENCES UNVEILS NEW AI ALGORITHM TO UNLOCK NATURE’S CHEMICAL CODE

Businesswire | June 26, 2023

Enveda Biosciences, a biotechnology company discovering new medicines from natural sources, released the details of one of its foundational AI models, MS2Mol, in a pre-print posted on ChemRxiv. MS2Mol is designed to predict the structure of metabolites, which are the building blocks and breakdown products of the cell. Despite their essential role in all cell processes, it is estimated that less than 1% of all naturally-occurring metabolites are known to science. The ability of MS2Mol to ra...

Read More
news image

MedTech, Industrial Impact

TWIST BIOSCIENCE ENTERS INTO THIRD COLLABORATION WITH ASTELLAS TO SUPPORT ANTIBODY DISCOVERY FOR IMMUNOTHERAPIES

Businesswire | April 21, 2023

Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. by which Astellas will license a suite of Twist’s VHH antibody libraries to be used by Astellas for drug discovery and development. “We are pleased to extend our collaboration with Astellas to three agreements across two groups within the company, showcasing our ab...

Read More
news image

Medical

BE BIO AND RESILIENCE ANNOUNCE STRATEGIC COLLABORATION TO MANUFACTURE ENGINEERED B CELLS, A NEW CLASS OF CELLULAR MEDICINES

Be Bio | May 20, 2022

Be Biopharma, Inc. (“Be Bio”) and National Resilience, Inc. (Resilience) today announced a strategic collaboration to advance initial programs in Be Bio’s rare disease pipeline. Be Bio’s proprietary engineered B Cell Medicines (BeCM) platform is harnessing the power of the human B cell to create a new class of autologous and allogeneic cellular medicines that durably and redosably produce therapeutic proteins in vivo without toxic pre-conditioning. The two ...

Read More

Resources

resource image

Cell and Gene Therapy, Industrial Impact

GMP Grade PMSF and Protease Inhibitors

Whitepaper

resource image

Cell and Gene Therapy, Industrial Impact

Characterization and identification of glucuronide metabolites

Whitepaper

resource image

Cell and Gene Therapy, Industrial Impact

GMP Grade PMSF and Protease Inhibitors

Whitepaper

resource image

Cell and Gene Therapy, Industrial Impact

Characterization and identification of glucuronide metabolites

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us